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Abstract: It is now widely-recognized that the view that herbal remedies have 
no adverse effects and/or toxicity is incorrect; some traditionally-used plants can 
present toxicity. The well-established popular use of Ageratum conyzoides has led to 
its inclusion in a category of medicinal crude drugs created by the Brazilian Health 
Surveillance Agency. Ageratum belongs to the Eupatorieae tribe, Asteraceae, and is 
described as containing toxic pyrrolizidine alkaloids. Aqueous extracts of Ageratum 
conyzoides L. harvested in Brazil (commercial, fl owering and non-fl owering samples) 
were prepared according to the prescribed method and analyzed by HPLC-HRMS. The 
pyrrolizidine alkaloids lycopsamine, dihydrolycopsamine, and acetyl-lycopsamine and 
their N-oxides, were detected in the analyzed extracts, lycopsamine and its N-oxide 
being known hepatotoxins and tumorigens. Together with the pyrrolizidine alkaloids 
identifi ed by HPLC-HRMS, thirteen phenolic compounds were identifi ed, notably, 
methoxylated fl avonoids and chromenes. Toxicological studies on A. conyzoides are 
necessary, as is monitoring of its clinical use. To date, there are no established safety 
guidelines on pyrrolizidine alkaloids-containing plants, and their use in Brazil.
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Introduction
 The Ageratum genus, Asteraceae, comprises 
ca thirty species that are not yet well-investigated. The 
widespread neotropical species Ageratum conyzoides L. 
is an annual aromatic plant that is considered an invasive 
and cosmopolite weed that grows in tropical areas, and 
is very common in Brazil. Its peculiar odour has been 
likened to the smell of goats, giving rise to the popular 
name of goatweed. In Brazil it has several names, such as 
mentrasto, maria-preta, picão-branco; picão-roxo, erva-de-
são-joão, erva-de-são-josé, erva-de-santa-lúcia. Ageratum 
conyzoides has a long history of medicinal use in several 
tropical countries around the world, and has a wide range 
of indications, from skin diseases to mental disorders and 
infectious diseases (Okunade, 2002).
 In Brazil, its aerial parts are widely used 
(internally and externally, fresh or dried, in tinctures 
or infusions) for their supposed analgesic and anti-
inflammatory properties, and are commonly used to 
treat menstrual cramps, arthritis, rheumatism, and 
diarrhea (Okunade, 2002; Lorenzi & Matos, 2008).
 The well-established popular use of this plant has 
led to its inclusion in the list of notifi ed herbal drugs, a 
category of medicinal crude drugs created by the Brazilian 
Health Surveillance Agency, Anvisa (RDC No. 10, March 
9th, 2010). This means the crude drug (aerial parts, 
crushed or powdered) is now authorized for marketing 
without medical prescription, for use in the preparation of 
infusions. 
 The majority of publications on the biological 
activity of A. conyzoides focus on its essential oil, and 
not on substances isolated from its extracts, such as 
pyrrolizidine alkaloids (PA), which were isolated from 
A. conyzoides collected in Kenya (Wiedenfeld & Roder, 
1991). These alkaloids are potentially hepatotoxic, and 
acute intoxications caused by PA are characterized by 
haemorrhagic liver necrosis in animals, being rare in 
humans. The main problem associated with PA is that 
long-term exposure can cause hepatic megalocytosis and 
veno-occlusive disease (to a lesser extent in the lungs), 
fatty liver degeneration and cirrhosis, and proliferation of 
the bile duct epithelium. Moreover, many PA are genotoxic 
and carcinogenic in rodents (Chen & Huo, 2010).
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 Since there is no published paper that confirms 
the presence of PA in the Brazilian Ageratum conyzoides, 
this work investigated the presence of PA in tea (aqueous 
extract) obtained by infusion of harvested plants (with 
and without flowers) and from a commercial sample 
(prepared according to the Anvisa procedure). It also 
attempted to isolate PA and further constituents from this 
medicinal plant. 
Material and Methods
Plant material
 The whole plant (Ageratum conyzoides L., 
Asteraceae) was harvested from the Garden of Medicinal 
Plants of the University Hospital of the Universidade 
Federal de Santa Catarina and from vacant lots near 
Praia Brava Beach, Florianópolis, SC. A voucher was 
identified by the botanist Renato Záchia and is deposited 
in the Herbarium of the Universidade Federal de Santa 
Maria (No. SMDB 13.138). The commercial sample was 
purchased from a Pharmacy in Ouro Preto, MG.
Plant processing and extraction
 The aerial parts of flowering and non-flowering 
species were separated and air-dried at 50 ºC (six days), 
then crushed, and stored in a refrigerator (4 ºC). The 
aqueous extract (infusion) was prepared by placing 3 g 
of crude drug in 150 mL of boiling water (according to 
RDC 10/10, Anvisa). The resulting aqueous extract was 
lyophilized and then analysed by NMR and HPLC-HRMS. 
The following samples were prepared: Flowering aerial 
parts (FS), non-flowering aerial parts (NFS), commercial 
sample (CS), purchased from a Pharmacy in Ouro Preto 
(MG).
 In order to isolate the main compounds, selective 
extraction of the crude drug with flowers (1 kg) was 
performed with solvents of increasing polarity, using 
n-hexane (28 g of n-hexane extract), dichloromethane (34 
g of dichloromethane extract), ethyl acetate (3 g of ethyl 
acetate extract) and ethanol (11 g of ethanol extract). From 
n-hexane extract, the following known compounds were 
obtained by classic silica gel CC, using several proportions 
of hexane-acetone as eluents (spectral data in accordance 
with the literature): β-sitosterol and stigmasterol 
(Kongduang et al., 2008), coumarin (1) (Kupriyanova, 
1997), precocene II (2) (Adebayo et al., 2010), encecalol 
and demethoxyencecalol (3 and 4) (González et al., 1991), 
sesamin (5) (Moazzami et al., 2007), linderoflavone B (6) 
(Saxena; Shrivastava, 1994), 3’-hydroxy-5,6,7,8,4’,5’-
hexamethoxyflavone (7) (Herz & Kulanthaivel, 1982), 5'-
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methoxynobiletin (8) (Le-Van & Van Cuong Pham, 1979), 
and eupalestin (9) (Herz et al., 1980). From the ethanol 
extract, the following were obtained: 2-hydroxycinnamic 
and 2-hydroxydihydrocinnamic acids (10 and 11) 
(Gerothanassis et al., 1998).
Pyrrolizidine alkaloids extraction procedures 
 In an attempt to isolate the PA, the method 
described previously for A. conyzoides by Wiedenfeld & 
Roder was reproduced, but without success. Additionally, 
traditional and improved methods for PA extraction were 
used, but no alkaloids were isolated (Frahn et al., 1980, 
Mroczek et al., 2006).
Aqueous extract fractionation
 In order to screen the chemical composition 
of the medicinal aqueous extract of A. conyzoides, CC 
fractionation was performed with Amberlite resin (Rohm 
and Hass Co) XAD-4 (230 g) and XAD-7 (250 g), using 
the hot aqueous extract (10 L), prepared according to the 
offi cial Brazilian method (M&M) (Figure 1). The non-
retained extract in the resin XAD-7 (i.e. the aqueous extract 
that eluted from the resin, 21 g) was solubilized in water 
and partitioned with n-butanol. The resulting fraction (5 g) 
was chromatographed in silica gel with an n-hexane-ethyl 
acetate-methanol gradient, leading to the identifi cation 
of two compounds (1.7 g of 2-hydroxycinnamic acid, 16 
and 2-hydroxydihydrocinnamic acid, 17). The aqueous 
extract retained in XAD-4 (eluted with methanol) yielded 
3.6 g, which was partitioned with dichloromethane (68.8 
mg) and chromatographed in silica gel with an n-hexane-
ethyl acetate-methanol gradient, furnishing 5.3 mg of 
compounds 16 and 17 and 8.5 mg of precocene II (8).
 All the other fractions obtained, shown in Figure 
1, were lyophilized and analyzed by UHPLC-HRMS: 
XAD-4 aqueous fraction, XAD-4 aqueous fraction after 
partition with dichloromethane, XAD-7 aqueous fraction, 
XAD-7 aqueous fraction after partition with ethyl acetate, 
and aqueous extract not retained in XAD.
 
Equipment
 NMR data for the isolated compounds were 
recorded on Bruker AVANCE 400 and AVANCE III 400 
NMR spectrometers, both operating at 9.4 T. 1H and 
13C nuclei were observed at 400.13 and 100.61 MHz, 
respectively. The spectrometers were equipped with 
either a 5 mm multinuclear direct detection probe with 
z-gradient or a 5 mm multinuclear inverse detection 
probe with z-gradient. One-bond and long-range 1H-13C 
correlations from HSQC and HMBC NMR experiments 
were performed with average coupling constants 1J(H,C) 
and LRJ(H,C) optimized for 140 and 8 Hz, respectively. The 
NMR chemical shifts are given in ppm related to the TMS 
signal at 0.00 ppm as internal reference. The UHPLC-ESI-
(+)-HRMS and UHPLC-ESI(+)-HRMS/MS analyses were 
performed using the Accela system (San Jose, CA, USA) 
equipped with a binary pump, autosampler, online vacuum 
degasser, and temperature-controlled column compartment. 
High resolution mass spectrometry was performed on a 
hybrid LTQ-Orbitrap XL Discovery mass spectrometer 
equipped with an ESI probe (Thermo Scientifi c, San Jose, 
CA, USA). 
Figure 1. Flow chart of the Ageratum conyzoides aqueous extract 
fractionation using Amberlite XAD-4 and XAD-7 resins. 
UHPLC-ESI(+)-HRMS & HRMS/MS analysis of extracts/
isolated compounds
 The solvents used in this study were of LC-MS 
grade, purchased from Fluka/Riedel-de Haën (St. Gallen, 
Switzerland). The freeze-dried extracts were stored in 
the dark at 4 oC prior to preparation for LC-MS, being 
diluted at the moment of analysis in MeOH at a fi nal 
concentration of 100 μg/mL. An Express Gold C18 100 
x 2.1, 3 μm reversed phase column (Thermo Scientifi c, 
Brehmen, Germany) was used at a fl ow rate of 300 μL/
min for the chromatographic separation. The mobile phase 
consisted of solvents A: water, 0.1% formic acid and B: 
ACN 0.1% formic acid. A gradient method (total run time 
of 20 min) was used for the profi ling of the samples as 
follows: 0 to 5 min: 5% B, 5 to 7 min: 25% B, 7 to 14 min: 
95% B, 14 to 16 min: 95% B, 16 to 17 min: 5% B and 17 
to 20 min: 5% B. The injection volume was 2 μL. The 
hybrid high resolution mass spectrometer (LTQ-Orbitrap 
Discovery XL) was operated in positive ion mode under 
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the following optimized conditions: capillary temperature, 
270 °C; capillary voltage, 20 V; tube lens, 110 V; source 
voltage, 3.5 kV; sheath gas flow, 40 arb. units; aux gas 
flow, 20 arb. units. Analysis was performed in full scan 
mode, with resolution of 30,000 at m/z 400 and  scan range 
set to m/z 100 -1000.
 For the HRMS/MS analysis, a “data-dependent” 
method was used, enabling the fragmentation of the three 
highest peaks detected for each scan. Two main scan 
events were performed successively, using only Orbitrap 
analyzers, the first consisting of a full scan (3 microscans, 
50000 injection time and 50-1000 m/z scan range) and the 
second consisting of three HRMS/MS acquisitions of the 
three most intense peaks (2 microscans, 10000 injection 
time, 45V CID / Q:0.25). 
Results and Discussion
 The use of herbal plants as natural remedies, 
functional foods, and dietary supplements for health care 
has been increasing worldwide. Market estimates suggest 
that the rate of growth in sales of traditional medicinal 
products in recent years has been between 5 and 18% per 
annum (Kohler & Baghdadi-Sabeti, 2011). It is now well-
recognized that the concept of no adverse effects and/or 
toxicity of natural products is an incorrect one (Li et al., 
2011). It is highly possible that PA-containing plants are 
the most common poisonous plants affecting livestock, 
wildlife, and humans, and are probably also the leading 
hepatotoxic and tumorigenic phytochemicals associated 
with human and animal diseases.
 Consequently, it is appropriate and imperative to 
identify plants and herbal products that contain toxic PA, 
and to assess the risk posed by exposure to these substances 
present in herbal products (Molyneux et al., 2011). It has 
been reported that 3% of all flowering plants contain PA, 
but they are primarily found in members of three plant 
families: Asteraceae, Boraginaceae and Fabaceae (Fu et 
al., 2002). 
 Ageratum belongs to the Eupatorieae 
tribe of the Asteraceae family, the Eupatorieae and 
Senecioneae tribes, the two described as containing the 
toxic PA compounds: 1,2-dehydropyrrolizidine ester 
alkaloids (dehydroPA, as in lycopsamine (12) and their 
N-oxides) (Hartmann & Conner, 2009). Worldwide, 
human hepatotoxicity due to 1,2-dehydropyrrolizidine 
alkaloids can be associated with the consumption of 
herbal remedies, the main problem being related to 
contamination of food or feed (Edgar et al., 2002).
 In mammals, ingested dehydroPA are oxidized in 
the liver by mixed-function oxidases (cytochrome P450) 
to pyrrole derivatives. The pyrrole ring system renders 
the C-7 and/or C-9 position highly electrophilic, and 
capable of reacting with tissue nucleophiles, concomitant 
with cleavage of the ester substituents, thereby binding to 
proteins and/or nucleic acids. This, in turn, can alter cell 
function, leading to cell damage or cell death (Molyneux 
et al., 2011).
 The presence of dehydroPA and its N-oxides 
has been reported in A. conyzoides harvested in Kenya 
(Wiedenfeld & Roder, 1991), Ethiopia (Wiedenfeld, 
2011) and Hawaii (Molyneux et al., 2011). PA and other 
toxins occur in low concentrations, and as predicted by 
the shifting defense hypothesis, toxin concentrations are 
significantly higher in invasive weed species than in native 
species (Doorduin & Vrieling, 2011). Ageratum is native 
to tropical America, and is highly invasive, especially 
under the drought conditions, which are alien to its natural 
environment. The shifting defense hypothesis could help 
explain why, in this work, it was not possible to isolate 
the alkaloids using the specific method described for these 
dehydroPA or using the same method as that previously 
used for the same species (M&M). 
 Aqueous extracts of A. conyzoides harvested in 
South Brazil (samples FS, NFS, CS), and its XAD fractions, 
were analyzed by HPLC-HRMS (Table 1) in full scan 
mode, to investigate the presence of the previously isolated 
dehydroPA isomers lycopsamine and echinatine, and other 
biogenetically related PA, such as acetyl-lycopsamine, 
dihydrolycopsamine and their N-oxide forms. 
 In the full scan HPLC-HRMS analysis, there 
were only a few peaks representing the relatively higher 
content of components in the TIC (Figure 2, 1st line); 
however, in the extracted ion chromatograms (XIC, 2nd to 
7th lines in Figure 2), six PA were detected. To verify their 
identities, HRMS/MS, generated by a newly developed 
data compound-dependent method for PA, were recorded. 
The resulting retention times, exact mass of protonated 
molecular ions, and characteristic fragment ions are 
summarized in Tables 1 and 3. In the full scan (TIC), 
six peaks with protonated molecular ions ([M+H]+) were 
observed at m/z 300.1805 (3.05 min, lycopsamine; 12), 
316.1755 (3.36 min, lycopsamine N-oxide, 13), 302.1962 
(3.38 min, dihydrolycopsamine, 14), 318.1911 (3.75 min, 
dihydrolycopsamine N-oxide, 15), 342.1911 (4.62 min, 
acetyl-lycopsamine, 16), and 358.1860 (4.83 min, acetyl-
lycopsamine N-oxide, 17). In the HRMS/MS experiment, 
these six peaks showed the characteristic retronecine-
type specific diagnostic fragment ion at 138 m/z (Table 
3). Of these six alkaloids identified, only two peaks were 
related to the dihydroPA form of lycopsamine and its 
N-oxide, which were not characterized as carcinogenic 
or hepatotoxic. It is important to note that together with 
the above mentioned PA, several mass isomers, mainly of 
dihydroPA, were also present (Figure 2, Table 1). 
 Few peaks were observed in the total ion 
chromatogram (TIC), confirming that the content of PA 
in the samples is low (Figure 2). Lycopsamine and its 
N-oxide were the two major PA (known hepatotoxins 
and tumorigens), while the other PA identified were only 
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Table 1. LC-HRMS data of compounds identified in aqueous extract samples of Ageratum conyzoides.
LC-HRMS analysis
Identification
Samples
Compounds
[M+H]+
CS¹ FS² NFS³
tR (min)
Theoretical 
m/z
Experimental 
m/z
Delta 
(ppm) RDB
Molecular 
Formula
1 3.05 300.1805 300.1811 2.00 3.5 C15H25O5N lycopsamine (12) ++ +++ +
2
2.90 
3.38 
4.03
302.1962
302.1966 
302.1967 
302.1966
1.32 
1.65 
1.32
2.5 C15H27O5N
dihydro-lycopsamine (14) 
possible isomer I  
possible isomer II
+ 
+
+ 
+
+ 
+
3 4.65 342.1911 342.1917 1.75 4.5 C17H27O6N acetyl-lycopsamine (16) + +++ ++
4 3.36 316.1755 316.1760 1.58 3.5 C15H25O6N lycopsamine N-oxide (13) +++ ++ +
5
3.21 
3.75 
3.94
318.1911
318.1915 
318.1915 
318.1915
1.26 
1.26 
1.26
2.5 C15H27O6N
dihydro-lycopsamine N-oxide (15) 
possible isomer I 
possible isomer II
+ 
++ 
++
+ 
+ 
+
+ 
+++ 
+++
6 4.83 11.99 358.1860
358.1866 
358.1869
1.68 
2.51 4.5 C17H27O7N
acetyl-lycopsamine N-oxide (17) 
possible isomer I
++ 
+
+ 
++
+++ 
+++
7 12.50 417.1180 417.1174 -1.44 11.5 C21H20O9 eupalestin (9) + + +
8 11.87 433.1493 433.1486 -1.62 10.5 C22H24O9 5'-methoxynobiletin (8) + + +
9 4.83 205.1223 205.1219 -1.95 5.5 C13H16O2 demethoxyencecalol (4) + + +
10 12.70 235.1329 235.1327 -0.85 5.5 C14H18O3 encecalol (3) + + +
12 12.66 167.0703 167.0700 -1.80 4.5 C9H10O3 2-hydroxydihydrocinnamic acid (11) + + +
13 10.95 163.1117 163.1113 -2.45 4.5 C11H14O 2,2-dimethylchromane + - -
14 5.96 223.1329 223.1324 -2.24 4.5 C13H18O3 3,4-dihydroprecocene II - - -
15 10.66 419.1337 419.1336 -0.24 10.5 C21H22O9
3’-hydroxy-5,6,7,8,4’,5’-
hexamethoxyflavone (7) + + +
16 11.68 387.1074 387.1065 -2.32 11.5 C20H18O8 linderoflavone  B (6) + + +
17 7.49 147.0441 147.0437 -2.72 6.5 C9H6O2 coumarin (1) + + +
18 12.14 221.1172 221.1169 -1.36 5.5 C13H16O3 precocene II (2) - + +
19 11.41 403.1387 403.1392 1.24 10.5 C21H22O8 5,6,7,3',4',5'-hexamethoxyflavone + + +
20 10.26 389.1231 389.1239 2.06 10.5 C20H20O8 ageconyflavone C + - -
¹Commercial sample; ²Flowering sample; ³Non-flowering sample.
minor ingredients in the plant. Analysing the data shown 
in Table 1, it can be clearly seen that in the non-flowering 
sample, the dihydro and N-oxide forms were predominant, 
but toxic dehydroPA were also present, contrary to the 
expectation that the plant would only produce these 
alkaloids when in flower, or only in the flowers, sequestered 
by butterflies (Hartmann & Ober, 2000). Moreover, due to 
the rhizomatous propagation of A. conyzoides, it is very 
difficult to separate the non-flowering from the flowering 
specimens. Despite the recommendation of Brazilian 
Health Surveillance Agency regarding the marketing of 
the non-flowering plant, only samples containing flowers 
were commercially available. In this work, we used 
only non-rhizomatous specimens for the non-flowering 
sample. Indeed, semi-quantitative comparison with the 
flowering and commercial samples showed that their 
alkaloid contents were very similar. 
 Together with the PA identified by HPLC-
HRMS, thirteen phenolic known compounds 
were detected in the aqueous extract, particularly 
methoxylated flavonoids and chromenes, together with 
coumarin and simple phenolics. Table 2 shows the PA 
distributed in various fractions, similar to the flavonoids 
after XAD fractionation, which was performed as 
shown in Figure 1. The possible role of these abundant 
phenolics in the medicinal qualities of this plant should 
also be explored, to determine both its beneficial and 
its adverse effects. 
Conclusions
 In the present study, hepatotoxic and tumorigenic 
PA and N-oxide PA were identified in A. conyzoides. The 
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Table 2. LC-HRMS data of compounds identified in XAD fractions of Ageratum conyzoides.
Identification
Samples
Not retainede
XAD4Aa XAD4AGb XAD7Ac XAD7AGd
lycopsamine (12) + + + + +
dihydrolycopsamine (14) + + + + -
acetyl-lycopsamine (16) - - - + -
lycopsamine N-oxide (13) + + + + +
dihydrolycopsamine N-oxide (15) - - - + -
acetyl-lycopsamine N-oxide (17) - + + + -
eupalestin (9) + + - + +
5'-methoxynobiletin (8) + + + + +
demethoxyencecalol (4) - - - - -
encecalol (3) - - - - -
2-hydroxydihydrocinnamic acid (11) + + - - -
2,2-dimethylchromane - - - - -
3,4-dihydroprecocene II - - - + -
3’-hydroxy-5,6,7,8,4’,5’-hexamethoxyflavone (7) - + + - -
linderoflavone  B (6) + + + + +
coumarin (1) - + + + -
precocene II (2) - - - -
5,6,7,3',4',5'-hexamethoxyflavone + + + + +
ageconyflavone C - + - - -
aXAD-4 aqueous fraction; bXAD-4 aqueous fraction after partition with dichloromethane; cXAD-7 aqueous fraction; dXAD-7 aqueous fraction after 
partition with ethyl acetate; eAqueous extract not retained in XAD.
Figure 2. Total ion chromatogram and extracted peaks obtained for the three analysed samples of Ageratum conyzoides aqueous 
extract, together with the respective extracted ion chromatograms (XIC), with several PA detected. 
Pyrrolizidine alkaloids in medicinal tea of Ageratum conyzoides
Cristiane F. Bosi et al.
Rev. Bras. Farmacogn. Braz. J. Pharmacogn. 23(3): May/Jun. 2013 431
use of extracts of this plant for medicinal preparations 
could potentially be harmful to human health, despite 
the low content of these substances in plants harvested in 
Brazil; chronic exposure to these toxigenic PA can present 
a risk of liver damage. In some countries, its clinical use 
is only authorized within certain limits. In Germany, for 
example, it is recommended that daily exposure to PA be 
no more than 0.1 mg for less than six weeks per year; and 
in Belgium, the limit for PA in plants is 1 ppm (1 mg per 
gram of plant) (Chen; Huo, 2010). Systematic toxicological 
studies on A. conyzoides with accurate quantification 
of toxic PA in plants are necessary, as is monitoring the 
clinical use of this drug. To date, there are no established 
safety guidelines on PA-containing medicinal plants and 
their use in Brazil.
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